Precigen reported a quarterly loss of $0.01 per share, beating the Zacks consensus loss of $0.10 by $0.09 and narrowing from a $0.04 loss a year ago (improvement of $0.03, a 75% reduction in loss magnitude). The modest earnings beat and year-over-year improvement are positive signals for the stock and could move the individual name modestly (roughly 1-3%).
Precigen reported a quarterly loss of $0.01 per share, beating the Zacks consensus loss of $0.10 by $0.09 and narrowing from a $0.04 loss a year ago (improvement of $0.03, a 75% reduction in loss magnitude). The modest earnings beat and year-over-year improvement are positive signals for the stock and could move the individual name modestly (roughly 1-3%).
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
